RU2005125411A - Применение конглютина для лечения диабета ii типа - Google Patents
Применение конглютина для лечения диабета ii типа Download PDFInfo
- Publication number
- RU2005125411A RU2005125411A RU2005125411/15A RU2005125411A RU2005125411A RU 2005125411 A RU2005125411 A RU 2005125411A RU 2005125411/15 A RU2005125411/15 A RU 2005125411/15A RU 2005125411 A RU2005125411 A RU 2005125411A RU 2005125411 A RU2005125411 A RU 2005125411A
- Authority
- RU
- Russia
- Prior art keywords
- conglutin
- gamma
- lupine
- proteins
- diabetes
- Prior art date
Links
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims abstract 3
- 241000219745 Lupinus Species 0.000 claims abstract 16
- 239000000203 mixture Substances 0.000 claims abstract 6
- 102000004169 proteins and genes Human genes 0.000 claims abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract 6
- 235000013305 food Nutrition 0.000 claims abstract 4
- 239000000284 extract Substances 0.000 claims abstract 3
- 239000003472 antidiabetic agent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 229940126904 hypoglycaemic agent Drugs 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 abstract 5
- 101710155000 Gamma conglutin 1 Proteins 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Claims (8)
1. Применение гамма-конглютина люпина или белков, обладающих более чем 50%-ной гомологией с гамма-конглютином люпина, для приготовления лекарственного препарата, пищевых добавок или продуктов питания для лечения диабета II типа.
2. Применение по п.1 гамма-конглютина люпина.
3. Применение по п.1, где указанные белки, обладающие более чем 50%-ной гомологией с гамма-конглютином люпина, выбранных из BG7S сои или EDGP моркови.
4. Применение по п.1 или 2 смеси белков люпина или экстракта, содержащего указанный гамма-конглютин.
5. Фармацевтические или пищевые композиции, содержащие в качестве активного ингредиента гамма-конглютин люпина или белки, обладающие более чем 50%-ной гомологией с гамма-конглютином люпина.
6. Фармацевтические или пищевые композиции по п.5, содержащие смеси белков люпина или экстракт, содержащий гамма-конглютин люпина.
7. Гамма-конглютин люпина в качестве терапевтического средства.
8. Гамма-конглютин люпина по п.7 в качестве сахаропонижающего средства.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2003A000237 | 2003-02-11 | ||
| IT000237A ITMI20030237A1 (it) | 2003-02-11 | 2003-02-11 | Uso della conglutina di lupino per il trattamento del |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2005125411A true RU2005125411A (ru) | 2006-01-27 |
| RU2339393C2 RU2339393C2 (ru) | 2008-11-27 |
Family
ID=32866063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005125411/15A RU2339393C2 (ru) | 2003-02-11 | 2004-02-06 | Применение конглютина для лечения диабета ii типа |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7323441B2 (ru) |
| EP (1) | EP1605957B1 (ru) |
| JP (2) | JP2006517212A (ru) |
| KR (2) | KR101084434B1 (ru) |
| CN (1) | CN1747739B (ru) |
| AT (1) | ATE391510T1 (ru) |
| AU (1) | AU2004212297B2 (ru) |
| CA (1) | CA2515607C (ru) |
| CY (1) | CY1108138T1 (ru) |
| DE (1) | DE602004012984T2 (ru) |
| DK (1) | DK1605957T3 (ru) |
| ES (1) | ES2303937T3 (ru) |
| IL (1) | IL170200A (ru) |
| IT (1) | ITMI20030237A1 (ru) |
| NO (1) | NO333224B1 (ru) |
| PL (1) | PL214193B1 (ru) |
| PT (1) | PT1605957E (ru) |
| RU (1) | RU2339393C2 (ru) |
| SI (1) | SI1605957T1 (ru) |
| WO (1) | WO2004071521A1 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
| HRP20140998T1 (hr) | 2008-05-30 | 2014-12-19 | Policlinico San Donato S.P.A.- Istituto Di Ricovero E Cura A Carattere Scientifico | Gama-konglutin kao lijek i dodatak prehrani |
| PT3130396T (pt) | 2009-03-27 | 2021-05-12 | Bend Res Inc | Processo de secagem por pulverização |
| EP2611529B1 (en) | 2010-09-03 | 2019-01-23 | Bend Research, Inc. | Spray-drying method |
| EP2611530B1 (en) | 2010-09-03 | 2019-01-16 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| EP2618924A1 (en) | 2010-09-24 | 2013-07-31 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
| PE20140589A1 (es) * | 2010-10-12 | 2014-05-24 | Consumo Em Verde Biotecnologia Das Plantas S A | Proteina antimicrobiana |
| WO2016000939A1 (de) * | 2014-06-30 | 2016-01-07 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewanden Forschung E.V. | Emulsion mit lupinenprotein |
| EP3212169B1 (en) | 2014-10-31 | 2021-01-13 | Bend Research, Inc. | Process for forming active domains dispersed in a matrix |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
| JPH08127538A (ja) * | 1994-10-31 | 1996-05-21 | Masakiyo Takahashi | 糖尿病治療薬 |
| JPH0967252A (ja) * | 1995-09-05 | 1997-03-11 | Zenkoku Royal Jelly Kosei Torihiki Kiyougikai | ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤 |
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
-
2003
- 2003-02-11 IT IT000237A patent/ITMI20030237A1/it unknown
-
2004
- 2004-02-06 CA CA2515607A patent/CA2515607C/en not_active Expired - Fee Related
- 2004-02-06 EP EP04708771A patent/EP1605957B1/en not_active Expired - Lifetime
- 2004-02-06 RU RU2005125411/15A patent/RU2339393C2/ru not_active IP Right Cessation
- 2004-02-06 US US10/545,103 patent/US7323441B2/en not_active Expired - Lifetime
- 2004-02-06 ES ES04708771T patent/ES2303937T3/es not_active Expired - Lifetime
- 2004-02-06 WO PCT/EP2004/001111 patent/WO2004071521A1/en not_active Ceased
- 2004-02-06 KR KR1020057014390A patent/KR101084434B1/ko not_active Expired - Fee Related
- 2004-02-06 AU AU2004212297A patent/AU2004212297B2/en not_active Ceased
- 2004-02-06 CN CN2004800039114A patent/CN1747739B/zh not_active Expired - Fee Related
- 2004-02-06 JP JP2006501760A patent/JP2006517212A/ja not_active Withdrawn
- 2004-02-06 PL PL377578A patent/PL214193B1/pl unknown
- 2004-02-06 SI SI200430714T patent/SI1605957T1/sl unknown
- 2004-02-06 AT AT04708771T patent/ATE391510T1/de active
- 2004-02-06 DE DE602004012984T patent/DE602004012984T2/de not_active Expired - Lifetime
- 2004-02-06 PT PT04708771T patent/PT1605957E/pt unknown
- 2004-02-06 KR KR1020117005984A patent/KR20110033312A/ko not_active Withdrawn
- 2004-02-06 DK DK04708771T patent/DK1605957T3/da active
-
2005
- 2005-08-10 IL IL170200A patent/IL170200A/en active IP Right Grant
- 2005-08-10 NO NO20053788A patent/NO333224B1/no not_active IP Right Cessation
-
2008
- 2008-06-12 CY CY20081100628T patent/CY1108138T1/el unknown
-
2012
- 2012-04-26 JP JP2012100564A patent/JP5504301B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| MXPA04007183A (es) | Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2. | |
| EP1173476A4 (en) | SOYBEAN PROTEIN NUTRIENTS | |
| WO2012049430A3 (fr) | Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices | |
| JP2017057147A (ja) | ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物 | |
| WO2019146735A1 (ja) | 侵害受容性疼痛の予防又は改善用組成物 | |
| RU2006131758A (ru) | Композиция для предупреждения простуды | |
| JP4904795B2 (ja) | 疲労改善剤組成物 | |
| AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
| WO2004028457A3 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY | |
| JP5854578B2 (ja) | 筋肉増強剤または基礎代謝増強剤 | |
| US20190183811A1 (en) | Composition containing squalene for improving muscle function and preventing muscle damage | |
| KR101574536B1 (ko) | 쿠마린산을 유효성분으로 포함하는 성장 촉진용 조성물 | |
| JP2019011278A (ja) | 育毛用可食性組成物 | |
| AU2001289762A1 (en) | Pharmaceutical extemporary compositions | |
| ES2343119T3 (es) | Composicion para la activacion del sistema inmune. | |
| US9226906B2 (en) | Method and nutritional supplement for enhancing weight gain of a mammal | |
| WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| JP2017043593A (ja) | 黒ニンニク及びビタミンｂ１を含有する組成物 | |
| JP6884302B2 (ja) | 黒ニンニク、及びＮａ含有量が２．０ｗｔ％以下である味噌からなる、疲労予防用の組成物 | |
| JP2007230987A (ja) | 抗肥満剤 | |
| JP2012180331A (ja) | 筋損傷の早期回復の誘導用の経口摂取剤 | |
| BR9917605A (pt) | Composição substituta de plasma | |
| ATE405584T1 (de) | Arginin/lysin-angereicherte peptide | |
| PL1768682T3 (pl) | Produkt pochodzenia roślinnego zawierający proantocyjanidyny i sposób jego wytwarzania |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200207 |